Patents Assigned to Universitat
-
Publication number: 20130140192Abstract: The present invention relates to a method of producing a lipid bilayer over a microcavity open on one side and to a microstructure for investigating lipid bilayers and an associated measuring arrangement. The method of producing a lipid bilayer over a microcavity open on one side comprises the following steps: filling the microcavity with an electrolyte solution; moving a fluid containing dissolved lipids in a first direction onto the microcavity; moving the fluid in a second direction away from the microcavity; monitoring the formation of the lipid bilayer over the microcavity by detecting an impedance between a counter-electrode connected to the fluid and a measuring electrode, which is arranged inside the microcavity.Type: ApplicationFiled: June 1, 2011Publication date: June 6, 2013Applicant: ALBERT-LUDWIGS-UNIVERSITÄT FREIBURGInventors: Jan Behrends, Gerhard Baaken
-
Publication number: 20130144137Abstract: A system and method are presented for use in monitoring one or more conditions of a subject's body. The system includes a control unit which includes an input port for receiving image data, a memory utility, and a processor utility. The image data is indicative of data measured by a pixel detector array and is in the form of a sequence of speckle patterns generated by a portion of the subject's body in response to illumination thereof by coherent light according to a certain sampling time pattern. The memory utility stores one or more predetermined models, the model comprising data indicative of a relation between one or more measurable parameters and one or more conditions of the subject's body. The processor utility is configured and operable for processing the image data to determine one or more corresponding body conditions; and generating output data indicative of the corresponding body conditions.Type: ApplicationFiled: August 1, 2012Publication date: June 6, 2013Applicants: Universitat de Valencia, Bar Ilan UniversityInventors: Zeev ZALEVSKY, Javier GARCIA, Vicente MICO, Michael BELKIN, Yevgeny BIEDERMAN, Israel MARGALIT, Revital BARELLY
-
Publication number: 20130143825Abstract: Compounds to be used in the treatment of diseases based on the expression of toxic transcripts. The present invention relates to peptide molecules, specifically hexapeptides, designed for the prevention and/or treatment of diseases the etiology whereof is based on the presence of toxic transcripts that comprise CUG, CCUG, CGG, CAG and AAG repeats, preferably: DM1 SCA8, DM2, FXTAS, HD and FA.Type: ApplicationFiled: March 9, 2011Publication date: June 6, 2013Applicants: UNIVERSITAT DE VALENCIA, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPE FELIPEInventors: Ruben Darío Artero Allepuz, Amparo Garcia López, Maria Del Mar Orzáez Calatayud, Maria Beatriz Llamusí Troisi, Enrique Pérez Payá, Manuel Pérez Alonso
-
Publication number: 20130142390Abstract: Methods and apparatus are described for monocular 3D human pose estimation and tracking, which are able to recover poses of people in realistic street conditions captured using a monocular, potentially moving camera. Embodiments of the present invention provide a three-stage process involving estimating (10, 60, 110) a 3D pose of each of the multiple objects using an output of 2D tracking-by detection (50) and 2D viewpoint estimation (46). The present invention provides a sound Bayesian formulation to address the above problems. The present invention can provide articulated 3D tracking in realistic street conditions. The present invention provides methods and apparatus for people detection and 2D pose estimation combined with a dynamic motion prior. The present invention provides not only 2D pose estimation for people in side views, it goes beyond this by estimating poses in 3D from multiple viewpoints. The estimation of poses is done in monocular images, and does not require stereo images.Type: ApplicationFiled: June 14, 2011Publication date: June 6, 2013Applicants: TECHNISCHE UNIVERSITÄT DARMSTADT, TOYOTA MOTOR EUROPE NV/SAInventors: Gabriel Othmezouri, Ichiro Sakata, Bernt Schiele, Mykhaylo Andriluka, Stefan Roth
-
Patent number: 8455435Abstract: The present invention relates to uses and methods of parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), for recruiting stem cells into tissue suffering from ischemia, wherein said stem cells are preferably capable of repairing and/or regenerating said tissue suffering from ischemia. Also provided is the use of a combination of G-CSF or a G-CSF fragment and a DPP IV inhibitor/antagonist in the medical intervention of an ischemic disorder. Accordingly, the uses and methods of the present invention are preferably suitable for the prevention and/or treatment of ischemia. Moreover, the present invention relates to a composition comprising parathyroid hormone (PTH), preferably PTH (1-34), and/or parathyroid hormone-related peptide (PTHrP), preferably PTHrP (1-34), and/or G-CSF or a G-CSF fragment for use as a pharmaceutical composition.Type: GrantFiled: March 24, 2009Date of Patent: June 4, 2013Assignee: Ludwig-Maximilians-Universitat MunchenInventors: Wolfgang M. Franz, Hans Theiss, Marc-Michael Zaruba, Stefan Brunner
-
Patent number: 8456493Abstract: A method is described for driving matrix displays which are made up of a plurality of lines with individual pixels, which lines are configured as rows and columns, wherein individual lines are driven selectively by rows being activated for a defined row addressing time and an operating current or a corresponding voltage being applied to the columns in correlation with the activated row corresponding to the desired brightness in the pixels. In order to improve the performance of the display, the row addressing time for each row is determined as a function of the maximum brightness of all the columns of the row.Type: GrantFiled: June 27, 2008Date of Patent: June 4, 2013Assignees: Universitat des Saarlandes, Kyocera Display Europe GmbH, Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.Inventors: Chihao Xu, Jürgen Wahl, Friedrich Eisenbrand, Andreas Karrenbauer, Kian Min Soh, Christoph Hitzelberger
-
Publication number: 20130136737Abstract: The present invention is directed to Nogo-A antagonists useful for the control of blood glucose or blood insulin levels in a subject and related use and formulation thereof. In particular, the invention is directed to Nogo-A antagonists useful for the prevention, repression or treatment insulin secretion deficiency and related methods and pharmaceutical formulations. In particular, the invention relates to Nogo-A antagonists useful in the treatment of diabetes mellitus.Type: ApplicationFiled: July 8, 2011Publication date: May 30, 2013Applicants: UNIVERSITAT ZURICH, UNIVERSITE DE GENEVEInventors: Pedro L. Herrera, Martin E. Schwab, Claire Bonal, Patrice Lalive D'epinay, Caroline Pot Kreis
-
Publication number: 20130137412Abstract: Methods and systems to decentralize managing of neighboring femtocells. The methods and systems include communication to a first femtocell from a second femtocell of next information that includes communicated information of: i) the interference requirement constraint of an active user of the second femtocell, and ii) one or more parameters characterizing a physical radio channel defined from the first femtocell to the at least one active user of the second femtocell; the self-configuration of the transmission parameters of the first femtocell based upon the communicated information i) and ii). Another method (and system to implement the method) includes the mutual adjustment of the interference requirement constraints between a first and a second femtocell, regarding their active users, in a decentralized manner, on the basis of not affecting the transmission performance of the rest of the plurality of femtocells.Type: ApplicationFiled: December 6, 2011Publication date: May 30, 2013Applicant: UNIVERSITAT POLITECHNICA DE CATALUNYA (UPC)Inventors: Javier Rodríguez Fonollosa, Adrián Agustin De Dios, Olga Muñoz Medina, Josep Vidal Manzano
-
Patent number: 8450229Abstract: Mix which comprises a) one or more very finely divided silicon dioxide powders having an average particle diameter of from 2 to 100 nm and a BET surface area of at least 30 m2/g, b) one or more particulate components selected from the group consisting of oxides, carbides and nitrides, in each case having an average particle diameter of from >0.5 ?m to 30 mm, c) one or more synthetic resins as binders and d) one or more metallic antioxidants having an average particle diameter of from >0.5 to 250 ?m. Process for producing a shaped body, in which to the mix is introduced into a mould, pressed if appropriate and heated to a temperature at which the synthetic resin crosslinks thermally. Shaped body which can be obtained therefrom. Process for producing a refractory shaped body, in which the shaped body is carbonized. Refractory shaped body which can be obtained therefrom.Type: GrantFiled: December 10, 2008Date of Patent: May 28, 2013Assignees: Evonik Degussa GmbH, Technische Universität Bergakademie Freiberg—Institut für Keremik, Glas-und BaustofftechnikInventors: Christos G. Aneziris, Uwe Klippel, Christoph Tontrup
-
Publication number: 20130131060Abstract: The present invention relates to a compound of formula (I) wherein R1, R2 and R3 are as defined in the description and the physiologically acceptable salts thereof as well as the physiologically acceptable solvates of the compounds of formula I and of the salts thereof. The compounds of formula I are suitable for treating tumors.Type: ApplicationFiled: December 10, 2010Publication date: May 23, 2013Applicant: Johannes Gutenberg-Universität MainzInventors: Gerd Dannhardt, Jan-Peter Kramb, Stanislav Plutizki
-
Publication number: 20130130906Abstract: 6-(alkylbenzylamino)purine derivatives of the general formula I for use as cytokinin receptor antagonists. R1 is selected from a group which includes, but is not limited to, hydroxyl, amino, nitro, thio and alkyl group. R2 denotes one to four alkyl groups. The invention also relates to preparations containing these derivatives and methods of using the derivatives.Type: ApplicationFiled: December 28, 2012Publication date: May 23, 2013Applicants: FREIE UNIVERSITAT BERLIN, UNIVERZITA PALACKEHO V OLOMOUCIInventors: UNIVERZITA PALACKEHO V OLOMOUCI, FREIE UNIVERSITAT BERLIN
-
Publication number: 20130129622Abstract: The present invention, among others, relates to a compound having a structure according to formula (I) or a pharmaceutically acceptable salt thereof, wherein Xaa1 to Xaa4 are independently of each other, an optionally N-alkylated natural or unnatural amino acid, R is H or methyl, L is a linker moiety, Ar is a spacer comprising an aromatic moiety, and D comprises, preferably is i) a combination of an organic complexation agent and a detectable label; or ii) a detectable label, an organic complexation agent or an active substance, said active substance particularly being selected from cytotoxic agents, lipids, sugars, sugar conjugates, sugar derivatives, proteins and combinations thereof, with the proviso that -L-Ar-D does not comprise a 18F-benzoyl residue.Type: ApplicationFiled: April 20, 2011Publication date: May 23, 2013Applicant: TECHNISCHE UNIVERSITÄT MÜNCHENInventors: Oliver DEMMER, Horst KESSLER, Hans-Jürgen WESTER, Margret SCHOTTELIUS, Ingrid DIJKGRAAF, Andreas Konard BUCK
-
Publication number: 20130127553Abstract: The invention relates to a parametric oscillator (1) for generating ultra-short pulses. The system (1) comprises a resonator (10) having an optical axis (11), an amplifier crystal (9) arranged in the resonator (10), and a pump laser system (4) for generating pump laser radiation (5) comprising pump photons, said pump laser radiation being directed onto the amplifier crystal (9). The invention is characterized in that the amplifier crystal (9) is an optically non-linear crystal configured for generating a signal photon and an idler photon from a pump photon by means of an optical-parametric process, wherein the resonator (10) is arranged in such a way that a signal pulse formed from the signal photons leaves the amplifier crystal (9) along the optical axis (11) of the resonator (10), and wherein dispersion compensation members for at least partially compensating the dispersion of the radiation circulating in the resonator (10) are provided.Type: ApplicationFiled: April 18, 2011Publication date: May 23, 2013Applicant: Gottfried Wilhelm Leibniz Universitat HannoverInventors: Uwe Morgner, Stefan Rausch, Thomas Binhammer
-
Publication number: 20130126725Abstract: A method for analysis of analytes in a sample and to the use of such a method and a method for monitoring progress, or treatment of a disease such as fat-related disease. These analysis methods include the steps of providing the sample, measuring of values of analytes in the sample, calculating of values based on the measured values, identifying and optionally visualizing analytes can particularly be used for monitoring quantitative changes of analytes and for monitoring progress or treatment of a disease such as a fat-related disease.Type: ApplicationFiled: July 26, 2011Publication date: May 23, 2013Applicant: TECHNISCHE UNIVERSITÄT GRAZInventors: Jurgen Hartler, Gerhard Thallinger
-
Patent number: 8445904Abstract: The invention relates to transparent rectifying contact structures for application in electronic devices, in particular appertaining to optoelectronics, solar technology and sensor technology, and also a method for the production thereof. The transparent rectifying contact structure according to the invention has the following constituents: a) a transparent semiconductor, b) a transparent, non-insulating and non-conducting layer composed of metal oxide, metal sulphide and/or metal nitride, the resistivity of which is preferably in the range of 102 ?cm to 107 ?cm and c) a layer composed of a transparent electrical conductor wherein the layer b) is formed between the semiconductor a) and the layer c) and the composition of the layer b) is defined in greater detail in the description of the patent.Type: GrantFiled: June 21, 2010Date of Patent: May 21, 2013Assignee: Universität LeipzigInventors: Marius Grundmann, Heiko Frenzel, Alexander Lajn, Holger von Wenckstern
-
Publication number: 20130123756Abstract: A medical device is disclosed, which comprises a functional unit (C) for permanent or temporary placement in the urogenital tract of a human or animal body. The functional unit has at least one electrically conducting portion. A power source (G) supplies a current to the electrically conducting portion after placement of the functional unit in the urogenital tract. In this manner, the growth of bacteria on the functional unit can be reduced.Type: ApplicationFiled: July 6, 2011Publication date: May 16, 2013Applicants: ETH ZURICH, UNIVERSITAT ZURICHInventors: Daniel Eberli, Lukas Hefermehl, Michael Gabi, Alexandre Lar-Magnac, Janos Voros
-
Publication number: 20130123622Abstract: The present invention relates to a balloon catheter system for draining and/or supplying fluid from/into hollow organs, body cavities or cysts, comprising a conduit catheter with an open distal end, a hollow needle guided in a separate guide conduit and a balloon surrounding the catheter stem at the distal end of the conduit catheter. The conduit catheter with the hollow needle can be inserted from outside into the hollow organ via a guide catheter, into the body cavity or cyst, the balloon can be filled with filling medium via the hollow needle through an opening formed in the guided duct and provided in the lumen of the balloon, and it can be fixed in the hollow organ, body cavity or cyst. The hollow needle can be removed from the guide duct after filling the balloon. The balloon and the conduit catheter remain in the hollow organ, body cavity or cyst.Type: ApplicationFiled: June 8, 2011Publication date: May 16, 2013Applicant: Universitätsmedizin der Johannes Gutenberg Universität MainzInventor: Michael Tchirikov
-
Publication number: 20130118619Abstract: The invention relates to a valve device for controlling a flow of a fluid through a fluid channel, having a tube (2) made of a flexible material, in which a section of a fluid channel is formed, a valve component (1) assigned to the tube (2), a cantilevered arm (8), which is designed to be reversibly displaceable on the valve component (1) against a restoring force supplied at least partially by the cantilevered arm (8) itself, a squeeze element (10), which is arranged on a distal end of the cantilevered arm (8) for support of the cantilevered arm (8) on the valve component (1) and is configured to control a flow of a fluid through the fluid channel by pressing against an outside surface of the tube (2), optionally up to the closing of the fluid channel, and an actuator (11) which is configured to displace the squeeze element (10) in various control directions against the restoring force on the cantilevered arm (8), so that the pressure of the squeeze element (10) on the outside surface of the tube (2) and thType: ApplicationFiled: June 1, 2011Publication date: May 16, 2013Applicant: TECHNISCHE UNIVERSITÄT BERLINInventors: Andreas Loth, Florian Bühs
-
Publication number: 20130122067Abstract: The invention relates to growth-inhibited hydroxyapatite for improving bone healing. It differs from the apatites employed to date in that it releases calcium ions and phosphate ions in physiological solutions, which, unlike traditional hydroxyapatites, it does not bind. It thereby promotes bone regeneration and bone growth. The growth-inhibited hydroxyapatite contains in agglomerates of prestructured collagen templates on which hydroxyapatite crystals with a crystallite growth of below its critical nucleus radius are formed epitactically. It is prepared by the steps a) mineralization of prestructured collagen templates in supersaturated Ca- and phosphate-ion-containing solutions, where the prestructured collagen templates are capable of diffusion and/or migration, so that HAP crystallites grow epitactically on the collagen templates and the collagen templates grown together with HAP crystallites agglomerate due to their capability of diffusion and/or migration, b) separating off the agglomerates.Type: ApplicationFiled: August 4, 2011Publication date: May 16, 2013Applicant: Technische Universitat DresdenInventors: Sascha Heinemann, Christiane Heinemann, Hartmut Worch, Thomas Hanke, Wolfgang Pompe
-
Publication number: 20130118697Abstract: The present invention relates to a bioprocess for recycling waste paper originated from high quality paper comprising the following steps: a) preparation of pulp; b) dilution with water of the pulped material obtained in a) c) enzymatic treatment of pulp; d) addition of inorganic salts and glues; e) dilution with water of the material obtained in d) f) filtration by vacuum; optional press; and g) drying In particular, said high quality paper is printed paper. The present invention also relates to the obtainable product by the above mentioned process. The present invention further relates to the different uses of the product such as building and construction material, eco-packaging material and eco-decorative material.Type: ApplicationFiled: May 16, 2011Publication date: May 16, 2013Applicant: Universitat Politecnica de CatalunyaInventor: Margarita Calafell Monfort